Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:CNAT
Delisted

Conatus Pharmaceuticals Inc. Stock Price (Quote)

$0.255
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.255 $0.255 Friday, 27th May 2022 CNAT stock ended at $0.255. During the day the stock fluctuated 0% from a day low at $0.255 to a day high of $0.255.
90 days $0.238 $0.275
52 weeks $0.203 $1.23

Historical Conatus Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Jun 15, 2016 $1.93 $2.02 $1.90 $1.92 80 382
Jun 14, 2016 $2.01 $2.02 $1.88 $1.92 171 331
Jun 13, 2016 $2.02 $2.07 $2.01 $2.01 59 615
Jun 10, 2016 $2.10 $2.10 $2.01 $2.02 46 866
Jun 09, 2016 $2.15 $2.17 $2.10 $2.12 119 568
Jun 08, 2016 $2.23 $2.23 $2.15 $2.17 123 292
Jun 07, 2016 $2.26 $2.27 $2.20 $2.21 63 222
Jun 06, 2016 $2.31 $2.35 $2.18 $2.25 99 688
Jun 03, 2016 $2.30 $2.43 $2.22 $2.29 50 608
Jun 02, 2016 $2.35 $2.37 $2.29 $2.31 139 880
Jun 01, 2016 $2.30 $2.40 $2.30 $2.36 216 926
May 31, 2016 $2.23 $2.35 $2.22 $2.30 217 881
May 27, 2016 $2.23 $2.25 $2.18 $2.21 60 605
May 26, 2016 $2.24 $2.28 $2.20 $2.25 143 397
May 25, 2016 $2.25 $2.26 $2.20 $2.24 75 698
May 24, 2016 $2.25 $2.26 $2.20 $2.24 53 171
May 23, 2016 $2.24 $2.26 $2.18 $2.24 175 185
May 20, 2016 $2.19 $2.24 $2.18 $2.23 78 812
May 19, 2016 $2.21 $2.25 $2.15 $2.17 79 467
May 18, 2016 $2.29 $2.31 $2.20 $2.21 44 076
May 17, 2016 $2.24 $2.33 $2.21 $2.30 118 161
May 16, 2016 $2.24 $2.29 $2.18 $2.23 74 395
May 13, 2016 $2.14 $2.22 $2.13 $2.22 111 546
May 12, 2016 $2.29 $2.30 $2.10 $2.15 141 655
May 11, 2016 $2.29 $2.31 $2.21 $2.26 76 027
Click to get the best stock tips daily for free!

About Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals. Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its product candidates include Emricasan, an orally active pan-caspase protease inhibitor that is in Phase II clinical trials for the treatment of liver cirrhosis, acute-on-chronic liver failure, post-orthotopic liver transplant as a result of hepatitis C virus infection with sust... CNAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT